Stocks
Acasti Pharma Inc.ACST
NASDAQHealthcareBiotechnology$3.37+4.01%
A clinical-stage biopharmaceutical company focused on developing therapies for rare and orphan diseases, with programs targeting neurological and cardiovascular conditions. Its pipeline includes drug candidates such as GTX-104, an intravenous formulation of nimodipine being studied for subarachnoid ...
Market Cap: $34.2M52W Range: $1.98 – $3.60
Congressional Interest in Acasti Pharma Inc. (ACST)
1 member of Congress has disclosed 1 trade in Acasti Pharma Inc. (ACST), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading ACST?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-03-16 | Mark Dr Green | buy | $1K – $15K |